In vitro antiplasmodial activity, pharmacokinetic profiles and interference in isoprenoid pathway of 2-aniline-3-hydroxy-1.4-naphthoquinone derivatives

[1]  J. S. Militão,et al.  Antimalarial ethnopharmacology in the Brazilian Amazon , 2015 .

[2]  Olivier Sperandio,et al.  FAF-Drugs3: a web server for compound property calculation and chemical library design , 2015, Nucleic Acids Res..

[3]  Vinícius Gonçalves Maltarollo,et al.  Applying machine learning techniques for ADME-Tox prediction: a review , 2015, Expert opinion on drug metabolism & toxicology.

[4]  S. Bourguignon,et al.  Evidences for leishmanicidal activity of the naphthoquinone derivative epoxy-α-lapachone. , 2014, Experimental parasitology.

[5]  E. Padilha,et al.  Evaluation of Antimalarial Activity and Toxicity of a New Primaquine Prodrug , 2014, PloS one.

[6]  A. Krettli,et al.  Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies , 2014, Memorias do Instituto Oswaldo Cruz.

[7]  V. Andrade-Neto,et al.  Comparative Study on the Antioxidant and Anti-Toxoplasma Activities of Vanillin and Its Resorcinarene Derivative , 2014, Molecules.

[8]  Philip Smith,et al.  Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinin-triazine hybrids and hybrid-dimers. , 2014, European journal of medicinal chemistry.

[9]  M. Lafuente,et al.  Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture , 2014, Malaria Journal.

[10]  F. Emery,et al.  In vivo antimalarial activity of novel 2-hydroxy-3-anilino-1,4-naphthoquinones obtained by epoxide ring-opening reaction. , 2013, Bioorganic & medicinal chemistry letters.

[11]  P. Rosenthal,et al.  Biological evaluation of hydroxynaphthoquinones as anti-malarials , 2013, Malaria Journal.

[12]  G. Wunderlich,et al.  Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparum , 2013, Malaria Journal.

[13]  A. Vaidya,et al.  The Antimalarial Activities of Methylene Blue and the 1,4-Naphthoquinone 3-[4-(Trifluoromethyl)Benzyl]-Menadione Are Not Due to Inhibition of the Mitochondrial Electron Transport Chain , 2013, Antimicrobial Agents and Chemotherapy.

[14]  G. Lian,et al.  Recent advances in predicting skin permeability of hydrophilic solutes. , 2013, Advanced drug delivery reviews.

[15]  Jonathan B. Baell,et al.  Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350, 000 Compounds , 2013, J. Chem. Inf. Model..

[16]  Barbara M. Bakker,et al.  Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism , 2013, PLoS neglected tropical diseases.

[17]  A. Hoerauf,et al.  New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. , 2012, European journal of medicinal chemistry.

[18]  K. Becker,et al.  Synthesis and biological evaluation of 1,4-naphthoquinones and quinoline-5,8-diones as antimalarial and schistosomicidal agents. , 2012, Organic & biomolecular chemistry.

[19]  Jignasa K. Savjani,et al.  Drug Solubility: Importance and Enhancement Techniques , 2012, ISRN pharmaceutics.

[20]  Lionel Colliandre,et al.  e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design , 2012, Bioinform..

[21]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[22]  Joseph L. DeRisi,et al.  Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum , 2011, PLoS biology.

[23]  E. Kimura,et al.  Isoprenoid biosynthesis in the erythrocytic stages of Plasmodium falciparum. , 2011, Memorias do Instituto Oswaldo Cruz.

[24]  V. Yardley,et al.  Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites. , 2011, Journal of the American Chemical Society.

[25]  E. Kimura,et al.  In Vitro and In Vivo Antiplasmodial Activities of Risedronate and Its Interference with Protein Prenylation in Plasmodium falciparum , 2011, Antimicrobial Agents and Chemotherapy.

[26]  P. Rosenthal,et al.  Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy , 2010, Malaria Journal.

[27]  F. L. D’Alexandri,et al.  Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone , 2010, FEBS letters.

[28]  Ian Collins,et al.  Probing the Probes: Fitness Factors For Small Molecule Tools , 2010, Chemistry & biology.

[29]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[30]  M. Edwards,et al.  Using the Golden Triangle to optimize clearance and oral absorption. , 2009, Bioorganic & medicinal chemistry letters.

[31]  A. Pawlak,et al.  Tocochromanols, plastoquinol, and other biological prenyllipids as singlet oxygen quenchers-determination of singlet oxygen quenching rate constants and oxidation products. , 2008, Free radical biology & medicine.

[32]  Kimberley A. Lentz,et al.  Current Methods for Predicting Human Food Effect , 2008, The AAPS Journal.

[33]  Daniel James,et al.  Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases , 2007, ChemMedChem.

[34]  S. Nunomura,et al.  In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plants. , 2007, Memorias do Instituto Oswaldo Cruz.

[35]  Alexander Hillisch,et al.  In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits , 2006, ChemMedChem.

[36]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[37]  C. Laggner,et al.  Why drugs fail--a study on side effects in new chemical entities. , 2005, Current pharmaceutical design.

[38]  Xiaolin Ma,et al.  Predictive model of blood-brain barrier penetration of organic compounds , 2005, Acta Pharmacologica Sinica.

[39]  I. Tetko,et al.  Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. , 2004, Journal of pharmaceutical sciences.

[40]  H. Kubinyi.  Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.

[41]  W. Patrick Walters,et al.  A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.

[42]  Manfred Kansy,et al.  Predicting plasma protein binding of drugs: a new approach. , 2002, Biochemical pharmacology.

[43]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[44]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[45]  A. Baggish,et al.  Antiparasitic Agent Atovaquone , 2002, Antimicrobial Agents and Chemotherapy.

[46]  A. Beresford,et al.  The emerging importance of predictive ADME simulation in drug discovery. , 2002, Drug discovery today.

[47]  John Hodgson,et al.  ADMET—turning chemicals into drugs , 2001, Nature Biotechnology.

[48]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[49]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[50]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[51]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[52]  Liliana R. Stefan,et al.  Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs , 2000 .

[53]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[54]  G. Bemis,et al.  Properties of known drugs. 2. Side chains. , 1999, Journal of medicinal chemistry.

[55]  Ajay,et al.  Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.

[56]  Xin Eric Wang,et al.  Vitamin E and its function in membranes. , 1999, Progress in lipid research.

[57]  D. Rees,et al.  Structure of the Escherichia coli fumarate reductase respiratory complex. , 1999, Science.

[58]  M. Yazdanian,et al.  Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.

[59]  S. D. Di Santi,et al.  In vivo and in vitro Plasmodium falciparum resistance to chloroquine, amodiaquine and quinine in the Brazilian Amazon. , 1997, Revista do Instituto de Medicina Tropical de Sao Paulo.

[60]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[61]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[62]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[63]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[64]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[65]  R. Trelstad,et al.  The collagen of chick embryonic notochord. , 1973, Biochemical and biophysical research communications.

[66]  W. R. Vaughan,et al.  Naphthoquinone Antimalarials. IV-XI. Synthesis1 , 1948 .

[67]  Marta Machado,et al.  Whole-cell SYBR Green I assay for antimalarial activity assessment , 2016 .

[68]  V. J. Peres,et al.  Intraerythrocytic stages of Plasmodium falciparum biosynthesize vitamin E , 2011, FEBS letters.

[69]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[70]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[71]  L. Fieser,et al.  Naphthoquinone antimalarials; synthesis. , 1948, Journal of the American Chemical Society.